Chalmers' Robot Scientist Aids Drug Discovery
Chalmers University of Technology has developed a robot scientist that utilizes artificial intelligence to automate scientific research, including drug discovery and development.
Chalmers University of Technology is developing AI-powered robot scientists capable of autonomously formulating hypotheses, planning and executing experiments, and analyzing results.
The robot "Eve," relocated from the University of Manchester to Chalmers, has previously succeeded in discovering novel drugs for tropical diseases such as malaria. The university states that AI systems now possess "superhuman" scientific skills that complement human researchers.
Chalmers Professor Ross King explains that the aim of these robot scientists is not to replace human researchers but to "make them orders of magnitude more productive through collaboration with AI systems." This approach aims to free human scientists to focus on higher-level creative tasks.
"Eve" has also been employed in the search for COVID-19 drugs, in collaboration with the University of Gothenburg. Additionally, Chalmers is developing a new robot scientist named "Genesis," intended to improve the understanding of human cell functions. This initiative is funded by the Wallenberg AI, Autonomous Systems and Software Program.